• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Cartesian Growth Corporation IV - Class A Ordinary Shares
Es Bancshares Inc
Full Metal Mnrls Ltd
Innovation Pharmaceuticals Inc
Sinda Ltd. Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

3.571 -0.179 (-4.78%)
Delayed Quote Updated: 2:21 PM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,253
Open 3.750
Bid (Size) 3.510 (600)
Ask (Size) 3.830 (400)
Prev. Close 3.750
Today's Range 3.510 - 3.970
52wk Range 3.080 - 40.60
Shares Outstanding 6,297,303
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
October 16, 2026
From Revelation Biosciences, Inc.
Via Business Wire
News headline image
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
August 19, 2026
From Revelation Biosciences, Inc.
Via Business Wire

Performance

52-Week Range 91.2% below 52-week high
3.571
3.0852W Low 40.6052W High
1 Week 34.6% below 1-week high
3.081W Low 5.461W High

Revelation Biosciences, Inc. - Common Stock (REVB) traded between $3.08 and $40.60 over the past 52 weeks and last traded at $3.57, 91.2% below its 52-week high. Over the past week it ranged between $3.08 and $5.46.

Past 12 Months
-29.1%
-47.8%
-55.6%
-56.0%
-84.3%
-89.9%
1W -$1.47
1M -$3.26
3M -$4.48
6M -$4.55
YTD -$19.20
1Y -$31.71

REVB was -89.9% over the past year, -56.0% over six months, -84.3% year to date, -29.1% in the last week.

12 Months vs Market
REVB
-89.9%
DIA
+12.6%
SPY
+15.0%
QQQ
+18.4%
IWM
+11.2%

Over the past 12 months REVB returned -89.9% versus DIA (Dow) +12.6%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +18.4% and IWM (Russell 2000) +11.2%.

Volume & Liquidity 1.45× 3-mo avg
Today 13,253 3-mo avg 9.2K
1W
59.6K
1M
18.4K
3M
9.2K
6M
8.4K
YTD
34.6K
1Y
28.5K

REVB most recently traded 13,253 shares against a 3-month average daily volume of 9.2K.

More News

Read More
Revelation Biosciences (NASDAQ:REVB) Surges on Pipeline Progress Despite Q2 Earnings Miss ↗
August 06, 2026
Via Chartmill
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
August 06, 2026
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
August 03, 2026
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 21, 2026
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
July 10, 2026
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
June 01, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
May 11, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
May 07, 2026
Via ACCESS Newswire
These stocks that are showing activity before the opening bell on Tuesday. ↗
April 07, 2026
Via Chartmill
News headline image
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
April 06, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
March 30, 2026
Via ACCESS Newswire
News headline image
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
March 24, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
March 19, 2026
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
February 26, 2026
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
January 26, 2026
Via Chartmill
News headline image
REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year ↗
January 26, 2026
Via Stocktwits
News headline image
American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements
January 26, 2026
Via AB Newswire
What's going on in today's session ↗
January 23, 2026
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
January 23, 2026
Via Chartmill
Which stocks are moving on Friday? ↗
January 23, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
January 23, 2026
Via Chartmill
Thursday's session: top gainers and losers ↗
January 22, 2026
Via Chartmill
News headline image
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
January 21, 2026
Via ACCESS Newswire

Frequently Asked Questions

Is Revelation Biosciences, Inc. - Common Stock publicly traded?
Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Revelation Biosciences, Inc. - Common Stock trade on?
Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?
The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market
What is the current price of Revelation Biosciences, Inc. - Common Stock?
The current price of Revelation Biosciences, Inc. - Common Stock is 3.571
When was Revelation Biosciences, Inc. - Common Stock last traded?
The last trade of Revelation Biosciences, Inc. - Common Stock was at 10/21/26 02:21 PM ET
What is the market capitalization of Revelation Biosciences, Inc. - Common Stock?
The market capitalization of Revelation Biosciences, Inc. - Common Stock is 22.49M
How many shares of Revelation Biosciences, Inc. - Common Stock are outstanding?
Revelation Biosciences, Inc. - Common Stock has 22M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap